The continuum of care: a paradigm for the management of metastatic colorectal cancer. - Wikidata - awgldk - TriplyDB

The continuum of care: a paradigm for the management of metastatic colorectal cancer.

The continuum of care: a paradigm for the management of metastatic colorectal cancer.

http://www.wikidata.org/entity/Q36709765

about

Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis.Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review Guanylyl cyclase C signaling axis and colon cancer prevention Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.Cost implications of new treatments for advanced colorectal cancer.Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice.Brain metastases in gastrointestinal cancers: is there a role for surgery?Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT.Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomes.Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: Meta-analysis of randomized controlled trials.The role of chemotherapy at the end of life: "when is enough, enough?".Medical treatment of advanced colorectal cancer in 2009.Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab.Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer.Episensitization: Defying Time's Arrow Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer.Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer.Use of bevacizumab in metastatic colorectal cancer: report from the Mexican opinion and analysis forum on colorectal cancer treatment with bevacizumab (September 2009)Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy.Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy.Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer.Patterns of practice with third-line anti-EGFR antibody for metastatic colorectal cancer.Longitudinal patterns of chemotherapy use in metastatic colorectal cancer.Current progress in targeted therapy for colorectal cancer.A postauthorization survey to document the therapeutic management of oxaliplatin as a first-line chemotherapy regimen in South Africa in patients with metastatic colorectal cancer.Cytotoxic triplets plus a biologic: state-of-the-art in maximizing the potential of up-front medical treatment of metastatic colorectal cancer.Treatment recommendations for metastatic colorectal cancer.Reintroduction of oxaliplatin: a viable approach to the long-term management of metastatic colorectal cancer.Optimal management of metastatic colorectal cancer: current status.Multidisciplinary approach of colorectal liver metastases.

P2860

Q24633957-8F491D9C-DDAA-44D5-8320-6F93BC929B36 Q26766244-C49399AD-1EEE-4224-B16D-C0E158912BBD Q27852105-1CCABE9D-8814-4A5E-AFA5-E643A9624652 Q28069495-7FD0B573-B924-46C6-ACB2-B82699659064 Q28074181-BBB3FF5E-14CC-4B52-A360-A2468407171D Q33497634-ABE229C5-7CB7-45EE-879A-B3114648EB49 Q33558630-F8CB1E4F-7BC9-44FD-8816-425AFAF80A8A Q33564901-FA9DE512-6514-4C83-B95D-49E567A33AE2 Q33651645-F7D4B075-BDE1-4779-AFAC-868E4EFEC231 Q33874203-5ADA3234-0197-442E-83BA-E43602A0BCDB Q34335079-F1AA75CF-35A7-490F-88A0-3F4E9436477B Q34358783-D3E2400A-7590-45BE-B591-0210D50FBE3F Q34396212-4608C5CF-DD17-4FF7-A7A3-7CFBB55158E1 Q34612932-E8694974-8A0E-44BA-B28D-B23C1E37C17B Q34639725-F21F33BD-2339-4F16-BC66-EBBD09214777 Q34997049-C1A2234F-0207-4AA4-858E-8CB2004E048F Q35076194-5E0591F8-7A82-4405-BED9-F9811664E78B Q35415181-78720DC2-5F2B-4DC8-9020-3721F851FCD4 Q35584314-65BB5E29-1BCA-4095-8EEE-644A5A1386BB Q35677265-9BE10AC2-0549-4B37-B9D9-9A825B596FE1 Q35726218-D3564F91-75BC-457B-86A6-D9FD30862971 Q35836495-614BCEB9-3F75-4A0E-969A-0CAEE23DD624 Q35953893-8A43EA42-12F0-4105-B339-38B0462C78DA Q35968430-CAEC5FBC-C193-406F-8877-294C81163763 Q36207072-BF849662-FA63-401D-8951-05545402A536 Q36444723-31684309-F977-4822-9341-A7F1AD7B7D54 Q36649513-8B7957CE-C4B3-4789-B9D1-EDAB0E8EE438 Q36942747-3BD2718A-4964-44E0-8365-DA8E4D991FBD Q36964966-340E111A-FBE4-4106-8821-27914B7E76C4 Q37141948-FEFBCBBA-1D28-4E66-B86C-1C5707002E4D Q37214304-BFE2AB43-8B13-4899-9EE5-11C8C6AA385F Q37367881-9CDECF36-C268-4727-BEE2-7B0261DD8F69 Q37466459-F503831F-33F7-49E1-91D9-02E8997152E5 Q37654660-C2F02674-E680-4C6C-A8E9-0DF9CAC2B749 Q37730640-E9B2DE3E-D628-4439-A0F7-86B82DC60B6B Q37832504-F6BD73CD-A611-4DCF-8D46-68B6D7BDFE74 Q37855303-C7169839-FFBB-4D41-AE78-F33F72FCB223 Q37859220-069CD4C1-7604-4181-85C0-4335B127B15F Q37875058-F3C1021E-4A8D-41C7-AE3C-C68AE871F592 Q37942736-2176D950-2DBF-4E75-96B7-726DEC6709D7

P2860

The continuum of care: a paradigm for the management of metastatic colorectal cancer.

http://www.wikidata.org/entity/Q36709765

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

The continuum of care: a paradigm for the management of metastatic colorectal cancer.

@ast

The continuum of care: a paradigm for the management of metastatic colorectal cancer.

@en

type

label

The continuum of care: a paradigm for the management of metastatic colorectal cancer.

@ast

The continuum of care: a paradigm for the management of metastatic colorectal cancer.

@en

prefLabel

The continuum of care: a paradigm for the management of metastatic colorectal cancer.

@ast

The continuum of care: a paradigm for the management of metastatic colorectal cancer.

@en

P1433

Q36709765-3AAB389C-5184-4FBA-A867-97495F9CDF38

P1476

Q36709765-3D053F72-AFDE-42F4-A8D5-73A89E38AB79

P2093

Q36709765-09264AB0-4B35-4B23-BF6B-2181C4458212

Q36709765-142E8590-EFB9-4E8A-BDEF-96AFC85473F6

Q36709765-59D74086-1788-4DD0-B6AE-629D61F8ADA1

Q36709765-5E2B5E9C-926D-4554-9C58-02BB763A2BCE

Q36709765-66E5B04F-2DBD-4E1A-8B38-2C818D2A5238

Q36709765-69CDE7B6-5DBE-4D6A-922C-40910931530A

Q36709765-90868DDE-A0E3-428F-AC9B-79F82D026454

Q36709765-91D77A20-69E7-4D9B-9D94-8A07ADAD415F

Q36709765-CA04893E-C91C-42A2-AF7B-3A942DED6630

Q36709765-F80209A0-5883-4324-A3CA-995A3FA59500

P304

Q36709765-3A32D116-E735-4B1C-8F5B-4C4C2E5EB912

P31

Q36709765-6207A359-14C4-496C-921F-9033003592D9

P356

Q36709765-BF6C1C96-0B2F-4D9D-BD9B-182D58681217

P433

Q36709765-10300EFC-4BD3-4C61-B4A6-0A1CBB12B97D

P478

Q36709765-B85CF853-ADE4-4C3B-BF8C-62182C8C4AAC

P50

Q36709765-1F3F4295-C38F-489A-8D7D-541CDD3B2DD1

Q36709765-A5D99CC8-2994-4756-92F9-69585D00BAD9

P577

Q36709765-2FE5DAEA-F0FD-40B8-9B76-298FB7EC6438

P5875

Q36709765-59B1DA06-18B7-4CAC-971D-3BCFA15DFD59

P698

Q36709765-F65D3E70-1AA7-4316-B0C0-9E517CC03638

P921

Q36709765-F00C602F-8236-440C-B72D-F922F7B84956

P356

THEONCOLOGIST.12-1-38

P1433

P1476

The continuum of care: a paradigm for the management of metastatic colorectal cancer.

@en

P2093

Al B Benson

http://www.w3.org/2001/XMLSchema#string

Axel Grothey

http://www.w3.org/2001/XMLSchema#string

Carlos H Roberto Becerra

http://www.w3.org/2001/XMLSchema#string

Carol Viele

http://www.w3.org/2001/XMLSchema#string

Charles D Blanke

http://www.w3.org/2001/XMLSchema#string

Delma Armstrong

http://www.w3.org/2001/XMLSchema#string

Mace L Rothenberg

http://www.w3.org/2001/XMLSchema#string

Neal J Meropol

http://www.w3.org/2001/XMLSchema#string

Ramesh K Ramanathan

http://www.w3.org/2001/XMLSchema#string

Richard M Goldberg

http://www.w3.org/2001/XMLSchema#string

P304

38-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.12-1-38

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Eric Van Cutsem

Heinz-Josef Lenz

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6574545

http://www.w3.org/2001/XMLSchema#string

P698

17227899

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer